Literature DB >> 20674812

Selection and characterisation of affibody molecules inhibiting the interaction between Ras and Raf in vitro.

Sebastian Grimm1, Emma Lundberg, Feifan Yu, Seiji Shibasaki, Erik Vernet, Marie Skogs, Per-Åke Nygren, Torbjörn Gräslund.   

Abstract

Development of molecules with the ability to selectively inhibit particular protein-protein interactions is important in providing tools for understanding cell biology. In this work, we describe efforts to select small Ras- and Raf-specific three-helix bundle affibody binding proteins capable of inhibiting the interaction between H-Ras and Raf-1, from a combinatorial library displayed on bacteriophage. Target-specific variants with typically high nanomolar or low micromolar affinities (K(D)) could be selected successfully against both proteins, as shown by dot blot, ELISA and real-time biospecific interaction analyses. Affibody molecule variants selected against H-Ras were shown to bind epitopes overlapping each other at a site that differed from that at which H-Ras interacts with Raf-1. In contrast, an affibody molecule isolated during selection against Raf-1 was shown to effectively inhibit the interaction between H-Ras and Raf-1 in a dose-dependent manner. Possible intracellular applications of the selected affibody molecules are discussed.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20674812     DOI: 10.1016/j.nbt.2010.07.016

Source DB:  PubMed          Journal:  N Biotechnol        ISSN: 1871-6784            Impact factor:   5.079


  6 in total

Review 1.  Targeting Ras with Macromolecules.

Authors:  Dehua Pei; Kuangyu Chen; Hui Liao
Journal:  Cold Spring Harb Perspect Med       Date:  2018-03-01       Impact factor: 6.915

2.  A Gradient of Sitewise Diversity Promotes Evolutionary Fitness for Binder Discovery in a Three-Helix Bundle Protein Scaffold.

Authors:  Daniel R Woldring; Patrick V Holec; Lawrence A Stern; Yang Du; Benjamin J Hackel
Journal:  Biochemistry       Date:  2017-03-09       Impact factor: 3.162

Review 3.  Protein scaffolds: antibody alternatives for cancer diagnosis and therapy.

Authors:  Renli Luo; Hongguang Liu; Zhen Cheng
Journal:  RSC Chem Biol       Date:  2022-05-25

4.  Report of the 24th Meeting on Signal Transduction 2021.

Authors:  Bastian Schirmer; Klaudia Giehl; Katharina F Kubatzky
Journal:  Int J Mol Sci       Date:  2022-02-11       Impact factor: 5.923

5.  Inhibitory effects of H-Ras/Raf-1-binding affibody molecules on synovial cell function.

Authors:  Seiji Shibasaki; Miki Karasaki; Torbjörn Gräslund; Per-Åke Nygren; Hajime Sano; Tsuyoshi Iwasaki
Journal:  AMB Express       Date:  2014-11-11       Impact factor: 3.298

Review 6.  Intracellular targeting with engineered proteins.

Authors:  Shane Miersch; Sachdev S Sidhu
Journal:  F1000Res       Date:  2016-08-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.